Novel diabetes drug may help people with heart failure, kidney disease

A unique diabetes drug called sotagliflozin (Zynquista) shows heart-related benefits in people with recently worsening heart failure or kidney disease in addition to diabetes. The drug is not yet approved for use in the United States.